[1]
L. R. Susanti, A. Mustika, L. D. Rahmawati, and C. D. K. Wungu, “Efficacy and Safety of Ozoralizumab versus Moxibustion for Rheumatoid Arthritis”, FMI, vol. 60, no. 4, pp. 358–371, Dec. 2024.